Dianthus Therapeutics (DNTH) revenue

Revenue · fiscal 2025
$2.04M

Dianthus Therapeutics (DNTH) reported revenue of $2.04M in fiscal 2025 (the year ended December 31, 2025). That is 67.3% lower than the $6.24M of fiscal 2024. Figures as of 18 Nov 2026, 05:22 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$2.04M
Change on fiscal 2024
−67.3%
Highest on record
$6.42Mfiscal 2022
Lowest on record
$2.04Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Dianthus Therapeutics revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $6.42M in fiscal 2022 and the lowest $2.04M in fiscal 2025.

History · 4 fiscal years

Revenue by fiscal year

Dianthus Therapeutics revenue, year by year

Dianthus Therapeutics (DNTH) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$2.04M 67.3% down
2024$6.24M 120.6% up
2023$2.83M 56.0% down
2022$6.42M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Dianthus Therapeutics and comparable companies
CompanyRevenueFiscal year
LivaNova LIVN$1.39B2025
Ionis Pharmaceuticals IONS$943.71M2025
Dianthus Therapeutics DNTH$2.04M2025
MiniMed Group MMED$3.10B2026
Adaptive Biotechnologies ADPT$276.98M2025
Heartflow HTFL$176.03M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DNTH

Dianthus Therapeutics, figure by figure

Dianthus Therapeutics (DNTH) overview: price, valuation and scorecardAll health care companies by market value

Dianthus Therapeutics revenue: questions and answers

What is Dianthus Therapeutics's revenue?

Dianthus Therapeutics (DNTH) reported revenue of $2.04M in fiscal 2025 (the year ended December 31, 2025). That is 67.3% lower than the $6.24M of fiscal 2024.

What are the highest and lowest revenue figures on record for Dianthus Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $6.42M in fiscal 2022 and the lowest $2.04M in fiscal 2025.

How is Dianthus Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dianthus Therapeutics (DNTH) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/DNTH/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.